Can Therapy Alter CNS Processing of Chronic Pain: A Longitudinal Study

Sponsor
University of Vermont (Other)
Overall Status
Unknown status
CT.gov ID
NCT01794988
Collaborator
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (NIH)
120
1
4

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate whether a psycho-therapeutic approach, group Cognitive Behavioral Therapy (CBT) plus a relapse prevention program, Therapeutic Interactive Voice Response (TIVR), modifies the dysfunctional sensory, emotional, and cognitive neural circuitry associated with chronic pain.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Group Cognitive Behavioral Therapy
  • Behavioral: Pain Education
  • Behavioral: Therapeutic Interactive Voice Response
  • Behavioral: NO TIVR
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Can Therapy Alter CNS Processing of Chronic Pain: A Longitudinal Study
Study Start Date :
Jul 1, 2010
Anticipated Primary Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group Cognitive Behavioral Therapy

Participants will undergo 11 weeks of group cognitive behavioral therapy (CBT) and a pre- and post-intervention MRI brain scan.

Behavioral: Group Cognitive Behavioral Therapy
Each CBT session will last 90 minutes and will teach participants specific skills to better cope with chronic pain. These skills will include breathing exercises, distraction, and relaxation techniques.

Active Comparator: Pain Education

Participants will receive 11 weeks of pain education and a pre- and post-intervention MRI brain scan.

Behavioral: Pain Education
Subjects will receive mailed educational materials to their homes on a weekly basis. Weekly materials will contain information about the nature of chronic back pain, treatment options, exercises and stretching techniques for maintaining strength and flexibility, and proper protection for a healthy back. Pain education is the standard of care for most outpatient clinics.

Experimental: Therapeutic Interactive Voice Response

Four months of therapeutic interactive voice response (TIVR).

Behavioral: Therapeutic Interactive Voice Response
Therapeutic Interactive Voice Response as a daily self monitoring and relapse prevention tool with didactic reviews and practices of recorded skills and monthly feedback based on daily calls.

Active Comparator: No TIVR

Control - no intervention

Behavioral: NO TIVR
Control - no intervention

Outcome Measures

Primary Outcome Measures

  1. Pain [Seven Months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • At least 12 months of muscular-skeletal, non-neuropathic pain
Exclusion Criteria:
  • Malignancy causing or influencing chronic pain

  • Radiation or chemotherapy, or metastatic cancer of any type

  • Reflex Sympathetic Dystrophy (RSD) and/or neuropathic pain

  • Neurological disorders such as epilepsy or stroke, or other medical conditions

  • Psychiatric disorders

  • Opioid medication use for pain management

  • Past year history of illicit drug use that can result in altered cognition

  • Pregnancy

  • Exceeding weight limit of the MRI scanner

  • Incompatible implants due to MRI safety

  • Awaiting pain related surgical procedure

  • Involved in pain-related litigation

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Vermont College of Medicine, MindBody Medicine Clinic Burlington Vermont United States 05401

Sponsors and Collaborators

  • University of Vermont
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Investigators

  • Principal Investigator: Magdalena Naylor, MD, PhD, Faculty, University of Vermont College of Medicine

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Magdalena Naylor, MD, PhD, Magdalena R. Naylor, MD, PhD, University of Vermont
ClinicalTrials.gov Identifier:
NCT01794988
Other Study ID Numbers:
  • R01AR059674-03
  • R01AR059674-03
First Posted:
Feb 20, 2013
Last Update Posted:
Feb 20, 2013
Last Verified:
Feb 1, 2013
Keywords provided by Magdalena Naylor, MD, PhD, Magdalena R. Naylor, MD, PhD, University of Vermont
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 20, 2013